XSES
42T
Market cap71mUSD
Aug 04, Last price
0.09SGD
Name
Trendlines Group Ltd
Chart & Performance
Profile
The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, clean technology, agritechnology, lifesciences with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs. The firm seeks to invest a minimum of $0.06 million in its portfolio companies. The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings. It leverages its own capital with government funding to mitigate risk in creating and developing new businesses. It is involved in all aspects of its portfolio companies from technology development to business building. The Trendlines Group Ltd. was founded in 1993 and is based in M.P. Misgav, Israel with additional offices in Tel Aviv, Israel; Beijing, China; and Singapore, Singapore.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 5,743 -127.36% | (20,988) -686.58% | 3,578 55.50% | |||||||
Cost of revenue | 1,927 | 11,347 | 12,564 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 3,816 | (32,335) | (8,986) | |||||||
NOPBT Margin | 66.45% | 154.06% | ||||||||
Operating Taxes | (601) | (2,156) | ||||||||
Tax Rate | ||||||||||
NOPAT | 3,816 | (31,734) | (6,830) | |||||||
Net income | (33,995) 0.00% | (33,995) 124.20% | (15,163) -331.04% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 5,645 | 6,370 | 7,470 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 727 | 752 | 711 | |||||||
Long-term debt | 4,940 | 5,936 | 6,236 | |||||||
Deferred revenue | 888 | |||||||||
Other long-term liabilities | 15 | 220 | (1,449) | |||||||
Net debt | (65,405) | (65,831) | (87,395) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (8,836) | (6,343) | (14,926) | |||||||
CAPEX | (27) | (78) | (112) | |||||||
Cash from investing activities | (948) | 1,922 | 2,049 | |||||||
Cash from financing activities | 8,645 | 5,966 | 3,133 | |||||||
FCF | 5,015 | (31,983) | (6,164) | |||||||
Balance | ||||||||||
Cash | 5,892 | 6,110 | 6,565 | |||||||
Long term investments | 65,180 | 66,409 | 87,777 | |||||||
Excess cash | 70,785 | 73,568 | 94,163 | |||||||
Stockholders' equity | (38,188) | (24,745) | 12,108 | |||||||
Invested Capital | 110,385 | 98,685 | 88,081 | |||||||
ROIC | 3.65% | |||||||||
ROCE | 5.29% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 18,448 | 18,561 | 840,459 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 4,540 | (31,550) | (8,056) | |||||||
EV/EBITDA | ||||||||||
Interest | 2,041 | 20 | 5,895 | |||||||
Interest/NOPBT | 53.49% |